Effects of platelet-rich plasma versus Hams F10 on the pregnancy outcome in infertile women with recurrent implantation failure

Effects of platelet-rich plasma versus Hams F10 on the pregnancy outcome in infertile women with recurrent implantation failure: a single blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201608319014N113

Enrollment

Registered

2016-09-09

Start date

2016-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intrauterine injection of 0.5 to 1 ml platelet-rich plasma 24 to 36 hours before implantation. Intervention 2: Intrauterine injection of 0.5 to 1 ml Hams F10 24 to 36 hours before impl

Treatment - Drugs

Intrauterine injection of 0.5 to 1 ml platelet-rich plasma 24 to 36 hours before implantation

Intrauterine injection of 0.5 to 1 ml Hams F10 24 to 36 hours before implantation

Eligibility

Sex/Gender

Female

Age

20 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 20 to 42 years; implantation failure for at least 3 times. Exclusion criteria: pregnancy contraindication; weak response to gonadotropin; presence of any type of chronic disease such as anemia or endocrine disorders or renal failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing pregnancy. Timepoint: 2 weeks after intervention. Method of measurement: with ßhCG.;Assessing pregnancy. Timepoint: 4 weeks after intervention. Method of measurement: with ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Marzieh Farimani

Fatemieh Hospital

dr_farimani@.yahoo.com+98 81 3828 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026